logo
Plus   Neg
Share
Email

Tech Data Q4 Results Top Estimates; Does Not Provide Outlook - Quick Facts

Tech Data Corp. (TECD) on Thursday reported net income for the fourth quarter of net income of $149.08 million or $4.15 per share, higher than $116.80 million or $3.11 per share in the year-ago quarter.

Excluding items, adjusted net income was $175.49 million or $4.88 per share, compared to $171.10 million or $4.55 per share in the prior-year quarter.

Net sales for the quarter were $10.38 billion, edging down 1 percent from $10.46 billion in the prior-year quarter. On a constant currency basis, net sales were flat.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $4.82 per share on net sales of $10.35 billion for the quarter. Analysts' estimates typically exclude special items.

As previously announced, the company said it Tech Data does not plan to host an earnings conference call nor provide forward-looking guidance due to the pending transaction with affiliates of Apollo.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
Follow RTT